Streetbeat News

Products Services

TELA

TELA Bio has announced the U.S. commercial launch of OviTex IHR, a product designed for use in laparoscopic and robotic-assisted inguinal hernia repair. This launch marks a significant step for TELA Bio in expanding its product offerings in the surgical repair market, potentially increasing its market share and revenue from sales of OviTex IHR.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:28 am

AAPL

CRM

GS

MTB

QQQ

SCHW

SPY

TSLA

U.S. stocks are poised for a rebound despite geopolitical tensions, with futures indicating a positive open. The SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket gains. Analysts highlight a buying opportunity in tech stocks, expecting a strong earnings season to drive growth. Tesla, Apple, and Salesforce faced premarket declines due to various concerns, while Goldman Sachs, M&T Bank, and Charles Schwab are set to report earnings. Economic data releases and Fed speakers are also in focus.

Portfolio Pulse from Shanthi Rexaline

April 15, 2024 | 11:27 am

EGRX

Eagle Pharmaceuticals announced it will present additional data from its Phase 3 trial on Amisulpride, a drug for postoperative nausea and vomiting, showing sustained response, at the ASPAN 2024 National Conference.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:25 am

LH

Labcorp announced the availability of the first test in the U.S. for Glial Fibrillary Acidic Protein, a biomarker for early detection of neurodegenerative diseases and neurological injuries. This development could position Labcorp as a leader in the diagnostic testing market for neurological conditions.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:16 am

SMX

SMXWW

SMX (Security Matters) PLC has successfully completed a proof of concept for ethical sourcing and authentication of silver in cooperation with SMI. This development marks a significant step for SMX in digitizing physical objects for a circular economy, potentially setting a new standard in the precious metals industry for ethical sourcing and authentication.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:12 am

TFFP

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) announced additional positive data from the Phase 2 study of Tacrolimus Inhalation Powder (TFF TAC) for preventing organ rejection in lung transplant recipients. The data was presented at the ISHLT 44th Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:11 am

BPTH

Bio-Path Holdings has expanded its intellectual property portfolio with new patents issued in Mexico, Australia, and Japan. This expansion includes filings that align with the company's technology and business strategy, bringing its total to five issued patents in the U.S. and 54 in foreign jurisdictions, covering 21 countries.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:09 am

CLWT

Euro Tech Holdings announced the formation of a new 'White Label' BWTS business partnership in Greece through its majority-owned subsidiary, Yixing PACT Environmental Technology Co., Ltd. This partnership involves an exclusive sales distribution and OEM agreement with ERMA FIRST ESK Engineering Solutions S.A.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:03 am

VTRS

Viatris has announced the launch of the first bioequivalent generic version of Copaxone 20 mg/mL for once-daily administration in Canada, marking a significant development in the availability of generic medications in the country.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 11:01 am

PLL

Piedmont Lithium (NASDAQ:PLL) has received approval from the North Carolina Department of Environmental Quality for a mining permit for the Carolina Lithium project in Gaston County, North Carolina. This permit allows for the construction, operation, and reclamation of the lithium project, which is crucial for the U.S. electric vehicle supply chain.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 10:56 am